v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Feb. 28, 2026
Feb. 28, 2025
Feb. 28, 2026
Feb. 28, 2025
Operating activities:        
Net earnings $ 45,120 $ 39,339 $ 106,970 $ 91,356
Adjustments to reconcile net earnings to net cash provided by operating activities:        
Depreciation and amortization 14,552 11,950 41,402 35,707
Provision for (benefit from) deferred income taxes 4,294 (8,016) 7,812 (10,871)
Bad debt (income) expense (97) 1,128 112 3,189
Equity in net income of unconsolidated affiliates, net of distributions 4,064 3,089 8,991 10,810
Net loss (gain) on sale of assets (17) (21) 2,995 (547)
Stock-based compensation 3,752 2,924 10,504 12,787
Unrealized loss on investment in marketable securities 340   1,584  
Changes in assets and liabilities, net of impact of acquisitions:        
Receivables (16,973) (18,553) 3,870 (9,023)
Inventories 10,998 14,128 (1,699) 15,558
Accounts payable 6,612 46 (3,365) (12,600)
Accrued compensation and employee benefits 13,658 8,838 (820) (4,628)
Other operating items, net (24,365) 2,279 (23,838) 15,592
Net cash provided by operating activities 61,938 57,131 154,518 147,330
Investing activities:        
Investment in property, plant and equipment (13,794) (12,704) (39,421) (37,494)
Acquisitions, net of cash acquired (212,191)   (304,426) (88,156)
Proceeds from sale of assets, net of selling costs 18 59 18 13,444
Investment in non-marketable equity securities, net of distributions (58) (833) (113) (2,873)
Net cash used by investing activities (226,025) (13,478) (343,942) (115,079)
Financing activities:        
Dividends paid (9,341) (8,422) (27,540) (25,507)
Repurchase of common shares (5,374) (6,170) (25,328) (21,052)
Net proceeds from short-term borrowings 4,792   4,792  
Principal payments on long-term obligations (284)   (760)  
Proceeds from issuance of common shares, net of tax withholdings (15) (22) (5,836) (7,073)
Net cash used by financing activities (10,222) (14,614) (54,672) (53,632)
(Decrease) increase in cash and cash equivalents (174,309) 29,039 (244,096) (21,381)
Cash and cash equivalents at beginning of period 180,288 193,805 250,075 244,225
Cash and cash equivalents at end of period $ 5,979 $ 222,844 $ 5,979 $ 222,844